s6y OPIANT PHARMACEUTICALS, INC. EFFECT

OPIANT PHARMACEUTICALS, INC. EFFECT, filed Mar 9, 2023: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 9, 2023
Accession Number: 0001385508-23-000091
Submission Type: POS AM
CIK: 0001385508
Company Name: OPIANT PHARMACEUTICALS, INC.
File Number: 333-220976